Mia D. Champion, PhD

Mayo Clinic, Rochester, MN, United States 
Bioinformatics Scientist
"Mia Champion"

PhD thesis with R.Scott Hawley


Sign in to add mentor
R Scott Hawley grad student 2002 UC Davis
 (Identification of genes that are dosage -sensitive modifiers of nod phenotype and act to properly segregate achiasmate chromosomes.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Borad MJ, Egan JB, Condjella RM, et al. (2016) Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25
Ho TH, Nateras RN, Yan H, et al. (2015) A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. Plos One. 10: e0132831
Ho TH, Park IY, Zhao H, et al. (2015) High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene
Yamada D, Rizvi S, Razumilava N, et al. (2015) IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism. Hepatology (Baltimore, Md.). 61: 1627-42
Zhu YX, Yin H, Bruins LA, et al. (2015) RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125: 483-91
Kortüm KM, Langer C, Monge J, et al. (2015) Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. British Journal of Haematology. 168: 507-10
Champion MD, Hlady RA, Yan H, et al. (2015) Bioinformatics strategies for identifying regions of epigenetic deregulation associated with aberrant transcript splicing and RNA-editing Bioinformatics 2015 - 6th International Conference On Bioinformatics Models, Methods and Algorithms, Proceedings; Part of 8th International Joint Conference On Biomedical Engineering Systems and Technologies, Biostec 2015. 163-170
Zhu YX, Braggio E, Shi CX, et al. (2014) Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood. 124: 536-45
Borad MJ, Champion MD, Egan JB, et al. (2014) Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135
Egan JB, Barrett MT, Champion MD, et al. (2014) Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. Plos One. 9: e87113
See more...